Topics

Companies Related to "Clovis Oncology Enters into Dilutive Clinical Trial Financing" [Most Relevant Company Matches] RSS

17:50 EDT 21st September 2019 | BioPortfolio

Here are the most relevant search results for "Clovis Oncology Enters into Dilutive Clinical Trial Financing" found in our extensive corporate database of over 50,000 company records.

Showing "Clovis Oncology Enters into Dilutive Clinical Trial Financing" Companies 1–25 of 6,200+

Extremely Relevant

Clovis Oncology, Inc.

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis intends to target development programs at specific subsets of cancer populations, and will simultaneously develop diagnostic tools that direct a compound in development to the population that is most...


Relevant

Accelerated Community Oncology Research Network, Inc.

ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Contract Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Massive Bio, Inc.

Massive Bio provides a comprehensive precision oncology access program to patients and enterprises – including virtual tumor board, clinical trial matching, reimbursement support and data analytics services. Massive Bio’s clinical trial matching customers are Contract Research Organizations (CROs), pharmaceutical companies and diagnostics labs. M...


CTC Clinical Trial Consulting

CTC Clinical Trial Consulting GmbH is a clinical research organisation based in Basel, Switzerland. CTC managers and partners have over 30 years working experience in the pharmaceutical industry. We have been established since 1997 and have built up a reputation as an honest, professional partner to our clients. Our professional experience covers all aspects of clinical research such as monitoring...

Novacea

We are a biopharmaceutical company focused on in-licensing, developing and commercializing novel therapies for the treatment of cancer. We currently have two clinical-stage oncology product candidates. Our lead product candidate, Asentar™ (DN-101), is in a Phase 3 clinical trial for the treatment of androgen-independent prostate cancer, or AIPC, also known as hormone-refractory prostate cancer. ...

Clinical Research Associate

Clinical Research Associate, also known as a Monitor, is an individual that oversees the progress and conduct of a clinical trial. A clinical trial is usually implemented by physicians at a hospital, clinic, or physician's office. The CRA is required to oversee the initiation, progress, and conduct of the clinical trial to ensure the scientific integrity of the data collected, and the protection o...

Qurient Co. Ltd.

Qurient is a clinical-stage biopharmaceutical company listed in Korea Exchange (KRX 115180). Qurient has two programs in clinical development and one program in the IND enabling stage. Q301 is a topical leukotriene inhibitor for atopic dermatitis in a Phase 2b clinical trial in the United States. Q702 is a Axl/Mer/CSF1R triple inhibitor for immune-oncology...

Intellikine, Inc.

Intellikine is a private, clinical-stage company focused on the discovery and development of innovative small molecule drugs targeting the PI3K/mTOR pathway. Intellikine recently announced the start of a Phase I trial for INK128, a selective TORC1/2 inhibitor for oncology and is advancing INK1197, a PI3K-delta/gamma dual-selective inhibitor for the treatment of inflammatory and respiratory diseas...

Trial By Fire Solutions

Trial By Fire Solutions is a global leader in web-based clinical trial management solutions and develops innovative applications to improve planning, execution and tracking of clinical studies. Since the release of its SimpleCTMS product, Trial By Fire Solutions has been providing affordable eClinical solutions to teams of all sizes.

OncoEthix

OncoEthix is a privately held biotechnology company that plans to develop a small portfolio of oncology drug candidates, ensuring a proper foundation for commercial success. The company’s lead product, OTX008, a synthetic small molecule targeted to galectin-1, entered Phase 1 clinical trial in the first quarter of 2012. OncoEthix was incorporated in 2007 and completed a Series A financing ...

Quantum Clinical Research

Global Clinical Trial/Project Management Therapeutic Specialization Phase I Clinical Trial Mgmt Capabilities Phase II-III Capabilities Phase IIIb –IV Capabilities Post marketing Surveillance Treatment IND & Compassionate Use Regulatory Operations & QA Capabilities Worldwide Drug Safety Clinical Trial Monitoring CRA/Monitor Training Select Biometrics Capabilities

GlycoGenesys, Inc.

GlycoGenesys, Inc. is a biotechnology company that develops and licenses products based on glycobiology. The Company's human therapeutic product, GCS-100, a unique compound to treat cancer has been evaluated in Phase II(a) human clinical trials for both colorectal and pancreatic cancers. In February 2002, the Company initiated a Phase I dose escalation trial of GCS-100 up to 80 mg/m2 at Sharp Clin...

Arch Oncology, Inc.

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. The Company’s next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative...

Provisio, Inc

Headquartered in Nashville, TN, Provisio, Inc. develops technologies and services that enhance clinical trial processes. Its flagship solution, iTrials, automates and streamlines the way drug trial candidates are identified, notified and enrolled. iTrials breaks the traditional paradigm associated with lengthy and costly clinical trial enrollment. Leveraging iTrials "unique-to-industry" data wareh...

Neogenix Oncology, Inc.

Neogenix Oncology is a development stage biotechnology company focused on developing and commercializing therapeutic and diagnostic products for the early detection and treatment of pancreatic, colorectal, lung, cervical, ovarian, prostate, and other cancers. The company’s portfolio includes monoclonal antibodies that are designed to be specific to ca...

Clinical Research Advantage, Inc.

Tempe, Ariz.-based Clinical Research Advantage, Inc. (CRA) is a provider of a range of research services to pharmaceutical companies and clinical research organizations (CROs). As a leading trial management organization (TMO), CRA operates from 29 sites across 12 geographic markets nationwide, helping trial sponsors bring drugs to market more quickly and e...

Salmedix Incorporated

Salmedix, Inc. is a San Diego-based biopharmaceutical company formed to in-license, develop and commercialize new cancer drugs, with an initial focus on hematologic cancers. Salmedix is developing novel therapies designed to be more effective and better tolerated than traditional cytotoxic cancer chemotherapy. The Company has licensed a portfolio of intellectual property invented in the laborator...

Clinical Assistance Programs

Clinical Assistance Programs (CAP) is a clinical trial management organization. CAP provides site and data quality management, investigator training, and specialized compliance services to life science companies engaged in clinical trials.CAP was created to address many of the problems inherent in the clinical trial process such as site variability, data accuracy, investigator compliance, and the ...

Nextrials, Inc

Nextrials is an innovative, award-winning, ileader in web-based software solutions for the clinical research industry. Prism®, the Company’s clinical trial management software, brings together sophisticated trial management and electronic data capture (“EDC”) in a single package enabling clinical researchers to derive more value from trial data, accelerate time to market and substantially l...

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals is a privately held biotechnology company focused on the development of products for oncology and ophthalmology treatment, including agents that inhibit angiogenesis. TRACON addresses unmet needs in these areas with first-in-class product candidates that will complement existing therapies. TRC093 is a monoclonal antibody that binds to cleaved collagen to inhibit angiogenesis...

Slope.io

Slope.io is a clinical trial supply chain logistics company. The company uses a modern, data-driven technology platform with predictive analytics to enable patient-centered, automated and end-to-end integrated services for clinical trial supplies. Trial data powers automated, just-in-time delivery of clinical supplies to study sites. For more information, ...

Aberdare Ventures

Formed in 1999, Aberdare Ventures is a San Francisco-based venture capital firm investing in visionary entrepreneurs and technologies that are transforming healthcare with new biological, engineering, and information technologies. The firm has attracted and partnered with many superior early stage companies such as Ironwood, Pharmion, Clovis Onco...

US Oncology Research

Supported by McKesson Specialty Health and The US Oncology Network, US Oncology Research draws from a network of experienced investigators and dedicated clinical staff who specialize in Phase I through Phase IV oncology clinical trials. US Oncology Research serves more than 85 practices in nearly 250 locations managing more than 225 active trials at any gi...

DHP pharma

DHP specialises in the preparation, packaging and distribution of Investigational Medicinal Products and Clinical Trial Supplies for study phases 1 through 4 and subsequent compassionate use.All work is carried out in accordance with the EU Clinical Trial Directive 2001/20 and Good Manufacturing Practice as set out by the MHRA. DHP offers a meticulous and comprehensive service from design through ...

Focus Bio-Inova, Inc.

Our project managers have many years of experience in handling the demanding requirements of specimens logistics, site support, and data management that make clinical trials a success. Focus project managers are often used by our clinical trial partners to help make their trial more efficient and cost effective. We also offer a unique Information Technology infrastructure that captures all aspects...


More From BioPortfolio on "Clovis Oncology Enters into Dilutive Clinical Trial Financing"

Quick Search

Corporate Database Quicklinks